Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,905.00
-70.00 (-1.76%)
At close: Feb 13, 2026
Market Cap59.85B +8.0%
Revenue (ttm)205.21B +12.4%
Net Income-1.37B
EPS-91.41
Shares Out15.33M
PE Ration/a
Forward PEn/a
Dividend75.00 (1.88%)
Ex-Dividend DateDec 29, 2025
Volume63,013
Average Volume126,873
Open3,990.00
Previous Close3,975.00
Day's Range3,900.00 - 3,990.00
52-Week Range3,400.00 - 6,130.00
Beta0.46
RSI41.27
Earnings Daten/a

About Korea Arlico Pharm

Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients. The company provides products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, NSAIDS and analgesics, ointment/cream, respiratory system, gastrointestinal, metabolic disease, antihistamines, anti-virus, genitourinary, alopecia, psychoneurotic, CNS, anthelmintics, and hypnotic diseases. Korea Arlico Pharm Co.,Ltd. w... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 112
Stock Exchange KOSDAQ
Ticker Symbol 260660
Full Company Profile

Financial Performance

Financial Statements